Fayetteville, Arkansas Clinical Trials

A listing of Fayetteville, Arkansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 27 clinical trials
Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)

This is a Phase III, randomized, parallel-arm, placebo controlled, double blind, multicenter study assessing the efficacy and safety of durvalumab versus placebo following SoC chemotherapy in patients with completely resected stage II-III NSCLC who are MRD+ post surgery

cancer chemotherapy
lung carcinoma
durvalumab
Research Site
 (1.2 away) Contact site
  • 102 views
  • 25 Jul, 2021
  • +245 other locations
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled with standard of care.

Research Site
 (1.2 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +227 other locations
Evaluation of ADG20 for the Prevention of COVID-19

This placebo-controlled study is intended to evaluate ADG20's safety and ability to prevent COVID-19 infection.

Adagio Investigative Site
 (7.4 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +39 other locations
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

The main purpose of this study is to measure how well abemaciclib works in participants with early breast cancer who are taking hormone therapy after surgery. Participants must have breast cancer that is hormone receptor positive (HR+) and human epidermal receptor 2 positive (HER2+). Your participation could last up to …

erbb2
hormone therapy
HER2
pertuzumab
invasive breast cancer
Highlands Oncology Group
 (6.3 away) Contact site
  • 0 views
  • 28 Jul, 2021
  • +535 other locations
Study of AZD2811 + Durvalumab in ES-SCLC

A Phase II Multicenter, Open-Label, Single Arm Study to Determine the Efficacy, Safety and Tolerability of AZD2811 and Durvalumab Combination as Maintenance Therapy After Induction with Platinum-Based Chemotherapy Combined with Durvalumab, for the First-Line Treatment of Patients with Extensive Stage Small-Cell Lung Cancer

platinum-based chemotherapy
cancer chemotherapy
etoposide
carboplatin
maintenance therapy
Research Site
 (1.2 away) Contact site
  • 0 views
  • 19 Jul, 2021
  • +34 other locations
Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors

This study is to assess the safety and tolerability, and to assess the preliminary clinical benefit of NKTR-214 when combined with pembrolizumab (KEYTRUDA) with or without chemotherapy. The study is comprised of two groups; dose optimization and dose expansion cohorts. Dose Optimization will include first-line and second-line melanoma, non-small cell …

proto-oncogene tyrosine-protein kinase ros
metastatic urothelial carcinoma
cancer treatment
pd-l1
ROS1
Investigator Site- Fayetteville
 (7.8 away) Contact site
  • 1682 views
  • 01 Aug, 2021
  • +66 other locations
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

This is an event driven, adaptive design, a randomized, active-controlled, multicenter, open-label, parallel groups, Phase 3 study of DSP-7888 Dosing Emulsion plus Bevacizumab versus Bevacizumab alone in patients with recurrent or progressive glioblastoma multiforme (GBM) following treatment with first line therapy consisting of surgery and radiation with or without chemotherapy.

bevacizumab
chemoradiotherapy
astrocytoma
aptt
tumor treating fields therapy
Highlands Oncology Group
 (1.2 away) Contact site
  • 1520 views
  • 31 Jul, 2021
  • +72 other locations
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

This study will test an experimental drug (enfortumab vedotin) alone and with different combinations of anticancer therapies. Pembrolizumab is an immune checkpoint inhibitor (CPI) that is used to treat patients with cancer of the urinary system (urothelial cancer). This type of cancer includes cancer of the bladder, renal pelvis, ureter …

gemcitabine
metastatic urothelial carcinoma
bacillus calmette-guerin
experimental drug
radical cystectomy
Highlands Oncology Group
 (1.2 away) Contact site
  • 284 views
  • 23 Jul, 2021
  • +92 other locations
Pivotal Randomized Open-label Study of Optune (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM

To test the effectiveness and safety of Optune given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM patients, compared to radiation therapy and temozolomide alone. In both arms, Optune and maintenance temozolomide are continued following radiation therapy.

karnofsky performance status
cancer
MRI
gross total resection
complete resection
Highland Oncology Group
 (1.2 away) Contact site
  • 0 views
  • 31 Jul, 2021
  • +156 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

florbetapir
positron emission tomography
flortaucipir
mini-mental state examination
alzheimer's disease
Health Initiatives Research
 (1.2 away) Contact site
  • 80 views
  • 24 Jul, 2021
  • +389 other locations